PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease

Clinical trial NCT07069595 · RECRUITING

Trial details

NCT number: NCT07069595
Sponsor: UNC Lineberger Comprehensive Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Residual Disease Triple Negative Breast Cancer (TNBC)Stage II/III

Start date: 2026-02-26
Primary completion: 2031-11-01
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.